Axsome Therapeutics (AXSM) Interest Coverage Ratio (2015 - 2026)
Axsome Therapeutics (AXSM) reported Interest Coverage Ratio of 9.94 for Q1 2026, down 11.19% on a YoY basis from 11.19 in Q1 2025, and down 12.45% sequentially from 8.84 in Q4 2025.
Axsome Therapeutics (AXSM) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
Axsome Therapeutics (AXSM) has 12 years of Interest Coverage Ratio data on file, last reported at 9.94 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 11.19% year-over-year to 9.94; the trailing twelve-month figure through Mar 2026 stood at 27.16 (up 35.94% YoY), and the FY2025 full-year result was 0.53, down 104.06% from the prior year.
- Interest Coverage Ratio slipped to 9.94 in Q1 2026, from 8.84 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 13.37 in Q4 2024 to a low of 34.06 in Q1 2022.
- A 5-year average of 8.76 and a median of 9.74 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio sank 2589.49% in 2023 and soared 166.24% in 2024, its largest moves.
- Tracing AXSM's Interest Coverage Ratio over 5 years: stood at 23.32 in 2022, then gained by 13.44% to 20.19 in 2023, then soared by 166.24% to 13.37 in 2024, then sank by 166.09% to 8.84 in 2025, then declined by 12.45% to 9.94 in 2026.
- Business Quant data shows AXSM's Interest Coverage Ratio at 9.94 in Q1 2026, 8.84 in Q4 2025, and 1.54 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Axsome Therapeutics | 12.37 Bn | 12.06 Bn | 176.48 Mn | -9.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.94 |
| Dec 31, 2025 | -8.84 |
| Sep 30, 2025 | -1.54 |
| Jun 30, 2025 | -1.20 |
| Mar 31, 2025 | -8.94 |
| Dec 31, 2024 | 13.37 |
| Sep 30, 2024 | -9.80 |
| Jun 30, 2024 | -12.21 |
| Mar 31, 2024 | -10.52 |
| Dec 31, 2023 | -20.19 |
| Sep 30, 2023 | -9.74 |
| Jun 30, 2023 | -10.21 |
| Mar 31, 2023 | -1.00 |
| Dec 31, 2022 | -23.32 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -34.06 |
| Dec 31, 2021 | -28.53 |
| Sep 30, 2021 | -0.18 |
| Jun 30, 2021 | -0.17 |